SE357365B - - Google Patents
Info
- Publication number
- SE357365B SE357365B SE08952/69A SE895269A SE357365B SE 357365 B SE357365 B SE 357365B SE 08952/69 A SE08952/69 A SE 08952/69A SE 895269 A SE895269 A SE 895269A SE 357365 B SE357365 B SE 357365B
- Authority
- SE
- Sweden
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19681770731 DE1770731A1 (de) | 1968-06-27 | 1968-06-27 | Neue blutzuckersenkende Sulfonamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE357365B true SE357365B (de) | 1973-06-25 |
Family
ID=5700618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE08952/69A SE357365B (de) | 1968-06-27 | 1969-06-24 |
Country Status (14)
| Country | Link |
|---|---|
| AT (3) | AT291255B (de) |
| BE (1) | BE735287A (de) |
| BR (1) | BR6908777D0 (de) |
| CH (1) | CH518968A (de) |
| DE (1) | DE1770731A1 (de) |
| DK (1) | DK123602B (de) |
| ES (1) | ES368100A1 (de) |
| FR (1) | FR2014300B1 (de) |
| GB (1) | GB1268835A (de) |
| IE (1) | IE33175B1 (de) |
| IL (1) | IL32396A (de) |
| NL (1) | NL6909960A (de) |
| NO (1) | NO124374B (de) |
| SE (1) | SE357365B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2048906A1 (de) * | 1970-10-06 | 1972-04-13 | Boehringer Mannheim Gmbh, 6800 Mannheim | Blutzuckersenkende Sulfonylaminopyrimidine und Verfahren zu deren Herstellung |
| EP1521577A1 (de) * | 2002-06-13 | 2005-04-13 | QLT, Inc. | Verfahren zur verwendung von isothiazolderivaten zur behandlung von krebs oder entzündungen |
-
1968
- 1968-06-27 DE DE19681770731 patent/DE1770731A1/de active Pending
-
1969
- 1969-05-14 BR BR208777/69A patent/BR6908777D0/pt unknown
- 1969-06-03 DK DK300869AA patent/DK123602B/da unknown
- 1969-06-05 CH CH860269A patent/CH518968A/de not_active IP Right Cessation
- 1969-06-06 ES ES368100A patent/ES368100A1/es not_active Expired
- 1969-06-13 IL IL32396A patent/IL32396A/xx unknown
- 1969-06-16 GB GB30406/69A patent/GB1268835A/en not_active Expired
- 1969-06-17 AT AT788770A patent/AT291255B/de not_active IP Right Cessation
- 1969-06-17 AT AT573169A patent/AT289109B/de not_active IP Right Cessation
- 1969-06-17 AT AT788870A patent/AT291256B/de not_active IP Right Cessation
- 1969-06-24 SE SE08952/69A patent/SE357365B/xx unknown
- 1969-06-25 IE IE873/69A patent/IE33175B1/xx unknown
- 1969-06-26 NO NO2659/69A patent/NO124374B/no unknown
- 1969-06-26 FR FR696921467A patent/FR2014300B1/fr not_active Expired
- 1969-06-27 NL NL6909960A patent/NL6909960A/xx unknown
- 1969-06-27 BE BE735287D patent/BE735287A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL32396A0 (en) | 1969-08-27 |
| ES368100A1 (es) | 1971-05-01 |
| NO124374B (de) | 1972-04-10 |
| FR2014300B1 (de) | 1973-01-12 |
| IE33175L (en) | 1969-12-27 |
| AT291255B (de) | 1971-07-12 |
| AT291256B (de) | 1971-07-12 |
| BE735287A (de) | 1969-12-29 |
| CH518968A (de) | 1972-02-15 |
| AT289109B (de) | 1971-04-13 |
| BR6908777D0 (pt) | 1973-01-23 |
| DK123602B (da) | 1972-07-10 |
| DE1770731A1 (de) | 1971-11-25 |
| GB1268835A (en) | 1972-03-29 |
| NL6909960A (de) | 1969-12-30 |
| FR2014300A1 (de) | 1970-04-17 |
| IE33175B1 (en) | 1974-04-03 |
| IL32396A (en) | 1972-06-28 |